Drug Type T cell antigen coupler-T cells |
Synonyms TAC201-Claudin18.2 (Allo), TAC 201 (Triumvira), TAC201 (Triumvira) + [1] |
Target |
Action inhibitors |
Mechanism CLDN18.2 inhibitors(Claudin 18.2 inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Ductal Adenocarcinoma | Preclinical | United States | 25 Apr 2024 | |
Stomach Cancer | Preclinical | United States | 25 Apr 2024 |